Table 5.
Baseline (N = 37) |
6 Month (N = 33) |
|||
---|---|---|---|---|
Outcome | Grading | n (%) | n (%) | P-valueb |
Maximuma BML size (including volume of any associated cyst), % | 0: None | 2 (5.4) | 1 (3.0) | 0.652 |
1: <33% | 7 (18.9) | 8 (24.2) | ||
2: 33–66% | 11 (29.7) | 13 (39.4) | ||
3: >66% | 17 (45.9) | 11 (33.3) | ||
Maximuma BML size (excluding cyst), % | 0: None | 2 (5.4) | 1 (3.0) | 0.647 |
1: <33% | 0 (0.0) | 1 (3.0) | ||
2: 33–66% | 3 (8.1) | 1 (3.0) | ||
3: >66% | 32 (86.5) | 30 (90.9) | ||
Whole joint synovitis/effusion score | 0 Normal | 11 (30.6) | 10 (31.3) | 0.855 |
1 Mild | 9 (25.0) | 7 (21.9) | ||
2 Moderate | 11 (30.6) | 8 (25.0) | ||
3 Severe | 5 (13.9) | 7 (21.9) | ||
Maximuma number of BMLs | 0 | 2 (5.4) | 1 (3.0) | 0.113 |
1 | 5 (13.5) | 6 (18.2) | ||
2 | 10 (27.0) | 9 (27.3) | ||
3 | 18 (48.6) | 9 (27.3) | ||
4 | 0 (0.0) | 5 (15.2) | ||
5 | 2 (5.4) | 3 (9.1) |
Maximum over all knee subregions.
Chi-squared test.